Rapid onset of haemodynamic effects after angiotensin converting enzyme-inhibitor overdose: Implications for initial patient triage

Emergency Medicine Journal

Volumn 23, Issue 11, 2006, Pages 854-857

  Lucas, C ^a   Christie, G A ^a   Waring, W Stephen ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; ENALAPRIL; LISINOPRIL; PERINDOPRIL; RAMIPRIL;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DATA COLLECTION METHOD; DIASTOLIC BLOOD PRESSURE; DRUG OVERDOSE; ELECTROCARDIOGRAM; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE PLANNING; HEART RATE; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MEDICAL CARE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; EMERGENCIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OVERDOSE; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; TIME; TRIAGE;

EID: 33750693415     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2006.038836     Document Type: Article

References (24)

1. Bennett K, Johnson H, Dock P, et al. Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002. Ir J Med Sci 2005;174:4-8.
2. Gnani S, Gray J, Khunti K, et al. Managing heart failure in primary care: first steps in implementing the National Service Framework. J Public Health 2004;26:42-7.
3. Augenstein WL, Kulig KW, Rumack BH. Captopril overdose resulting in hypotension. JAMA 1988;259:3302-5.
4. Park H, Purnell GV, Mirchandani HG. Suicide by captopril overdose. J Toxicol Clin Toxicol 1990;28:379-82.
5. Barr CS, Payne R, Newton RW. Profound prolonged hypotension following captopril overdose. Postgrad Med J 1991;67:953-4.
6. Varon J, Duncan SR. Naloxone reversal of hypotension due to captopril overdose. Ann Emerg Med 1991;20:1125-7.
7. Jackson T, Corke C, Agar J. Enalopril overdose treated with angiotensin infusion. Lancet 1993;341:703.
8. Newby DE, Lee MR, Gray AJ, et al. Enalapril overdose and the corrective effect of intravenous angiotensin II. Br J Clin Pharmacol 1995;40:103-4.
9. Dawson AH, Harvey D, Smith AJ, et al. Lisinopril overdose. Lancet 1990;335:487-8.
10. Trilli LE, Johnson KA. Lisinopril overdose and management with intravenous angiotensin II. Ann Pharmacother 1994;28:1165-8.
11. Varughese A, Taylor AA, Nelson EB. Consequences of angiotensin-converting enzyme inhibitor overdose. Am J Hypertens 1989;2:355-7.
12. Johnston GD, Smith AM. Management of overdose due to antihypertensive agents. Adverse Drug React Acute Poisoning Rev 1990;9:75-89.
13. Lip GY, Ferner RE. Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. Hypertension 1995;9:711-15.
14. Roberge RJ, Rossetti ML, Rosetti JM. Aminophylline reversal of antihypertensive agent toxicity. Vet Hum Toxicol 2001;43:285-7.
15. Bateman DN, Good AM, Laing WJ, et al. TOXBASE: poisons information on the internet. Emerg Med J 2002;19:31-4.
16. World Health Organization Collaborative Centre for Drug Statistics Methodology. ATC/DDD Index 2006. http://www.whocc.no/atcddd (accessed 31 Aug 2006).
17. Gornbein JA, Lazaro CG, Little RJ. Incomplete data in repeated measures analysis. Stat Methods Med Res 1992;1:275-95.
18. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-15.
19. Kenward MG, Molenberghs G. Parametric models for incomplete continuous and categorical longitudinal data. Stat Methods Med Res 1999;8:51-83.
20. Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation 1998;97:1411-20.
21. Giannettasio C, Grassi G, Seravalle G, et al. Investigation of reflexes from volume and baroreceptors during converting-enzyme inhibition in humans. Am Heart J 1989;117:740-5.
22. Shrank WH, Ettner SL, Glassman P, et al. A bitter pill: formulary variability and the challenge to prescribing physicians. J Am Board Fam Pract 2004;17:401-7.
23. Song JC, White CM. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet 2002;41:207-24.
24. Lopez-Sendon J, Swedberg K, McMurray J, et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The task force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004;25:1454-70.